Nebacumab is a human monoclonal antibody developed for the treatment of sepsis.

[1] It has been withdrawn in 1993 because it failed to reduce mortality in clinical trials.

[2] This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.This monoclonal antibody–related article is a stub.

You can help Wikipedia by expanding it.